American Northwest University – …Where Your Future Begins

we
make
doctors

All Clinical rotations in the united states will help you secure your residency

- 6 years md program
- 4 years md program

join us

OUR PROGRAMS

Six year MD program

Requires High school diploma with major in Biology. Students can do three years at the main campus and have the option to do the clinical rotations in Chicago, USA.

Four year MD program

Designated for students who already finished premedical program. Students can do four semesters at the main campus and have the option to do the fifth semester and clinical rotations in Chicago, USA.

ESL (English as a Second Language) Courses

ESL classes are available to non-native English-language students to help them on English proficiency tests and to master their English language skills.
Improve your English quickly and effectively. Each of our courses has a special focus, allowing you to direct your studies in the way that best suits you. These courses prepare you for the colleague level of English language prior to your enrollment in the MD program.

INTERNATIONAL MEDICAL NEWS

Study: Variable outcomes of stem cell injections for knee osteoarthritis
on August 7, 2026
Knee osteoarthritis (KOA) affects more than 1 in 10 people older than 40, impairing patients' mobility and quality of life. With limited treatment options, stem cell injections have been promoted as a treatment, but clinical trial evidence of efficacy is often lacking, despite claims from clinics […]
Greater intentions to take hypertension medication, fewer intentions to change lifestyle
on August 7, 2026
Having high blood pressure is associated with greater intentions to follow doctors' recommendations to take medication but lower intentions to make recommended lifestyle changes than among people without high blood pressure, according to a new study published in Hypertension.
Study identifies promising therapy to prevent relapses in rare neurological disease
on August 7, 2026
An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). MOGAD is a rare autoimmune neurological disorder that can cause […]